| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Second Regular National Report on the Implementation of the Cartagena Protocol on Biosafety
Record information and status
Record ID
102274
Status
Published
Date of creation
2011-09-07 20:14 UTC (andrew.bowers@cbd.int)
Date of last update
2011-11-08 20:50 UTC (andrew.bowers@cbd.int)
Date of publication
2011-11-08 20:50 UTC (andrew.bowers@cbd.int)

This document is also available in the following languages:
Origin of report
Country
  • Burundi
Contact officer for report
Coordinates
Vincent MUHITIRA
Directeur Général et Point Focal de la CDB
Institut National pour l'Environnement et la Conservation de la Nature
B.P. 56
GITEGA
Burundi
Phone:257 22 40 30 32
Email:inecndg@yahoo.fr
Consulted stakeholders
9. Organizations/stakeholders who were consulted or participated in the preparation of this report
FR
Des représentants des ministères concernés:  environnement, agriculture, éducation et recherche scientifique, commerce et industrie, santé publique, des associations de la société civile, du secteur privé, des associations de consommateurs ont pris part au processus.
Submission
10. Date of submission
2011-09-07
11. Time period covered by this report
Start date
2008-12-31
Time period covered by this report
End date
2011-09-07
Party to the Cartagena Protocol on Biosafety
12. Is your country a Party to the Cartagena Protocol on Biosafety (CPB)?
  • Yes
Article 2 – General provisions
15. Has your country introduced the necessary legal, administrative and other measures for the implementation of the Protocol?
  • Only a draft framework exists
16. Which specific instruments are in place for the implementation of your national biosafety framework?
  • One or more sets of biosafety guidelines
17. Has your country established a mechanism for the budgetary allocations of funds for the operation of its national biosafety framework?
  • No
18. Does your country have permanent staff to administer functions directly related to the national biosafety framework?
  • Yes
19. If you answered Yes to question 18, how many permanent staff members are in place whose functions are directly related to the national biosafety framework?
  • Less than 5
20. Has your country’s biosafety framework / laws / regulations / guidelines been submitted to the Biosafety Clearing-House (BCH)?
  • Partially
21. Here you may provide further details on the implementation of Article 2 in your country:
FR
Le Burundi a déjà mis en place un Cadre National de Biosécurité et un projet de loi sur la biosécurité se trouve à la table du gouvernement. Le Cadre National de Biosécurité  donne toutes les mesures et les organes nécessaires pour la mise en œuvre le Protocole de Cartagena sur la Prévention des Risques Biotechnologiques. Les organes actuellement fonctionnels sont l'Autorité Nationale Compétente,  le Point Focal du Protocole et celui du Biosafety Clearing House (BCH). D'autres organes prévus par le Cadre National de Biosécurité notamment le Comité National Consultatif, le Comité National d'Experts et le Comité National Public ne sont pas encore mis en place du fait que la loi n'est pas encore adoptée.
Article 5 – Pharmaceuticals
22. Does your country regulate the transboundary movement, handling and use of living modified organisms (LMOs) which are pharmaceuticals?
  • No
24. Here you may provide further details on the implementation of Article 5 in your country:
FR
Le Burundi, dans son Cadre National de Biosécurité et son projet de loi y relatif, a mis une importance capitale sur les OGM  sans accent particulier sur les produits pharmaceutiques pouvant relever d'autres accords ou organismes internationaux pertinents comme l'OMS.
Article 6 – Transit and Contained use
25. Does your country regulate the transit of LMOs?
  • No
26. Does your country regulate the contained use of LMOs?
  • No
28. Here you may provide further details on the implementation of Article 6 in your country:
FR
Le pays n'a pas encore adopté la loi sur la biosécurité qui contient des dispositions en rapport avec le transit des OVM et l'utilisation des OVM en milieu confiné
Articles 7 to 10 – Advance Informed Agreement (AIA) and intentional introduction of LMOs into the environment
29. Has your country adopted law(s) / regulations / administrative measures for the operation of the AIA procedure of the Protocol?
  • No
30. Has your country adopted a domestic regulatory framework consistent with the Protocol regarding the transboundary movement of LMOs for intentional introduction into the environment?
  • No
31. Has your country established a mechanism for taking decisions regarding first intentional transboundary movements of LMOs for intentional introduction into the environment?
  • No
33. Has your country established a mechanism for monitoring potential effects of LMOs that are released into the environment?
  • No
34. Does your country have the capacity to detect and identify LMOs?
  • No
35. Has your country established legal requirements for exporters under its jurisdiction to notify in writing the competent national authority of the Party of import prior to the intentional transboundary movement of an LMO that falls within the scope of the AIA procedure?
  • No
36. Has your country established legal requirements for the accuracy of information contained in the notification?
  • No
37. Has your country ever received an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • No
38. Has your country ever taken a decision on an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • No
41. In the current reporting period, how many applications/notifications has your country received regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • None
42. In the current reporting period, how many decisions has your country taken regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • None
50. Here you may provide further details on the implementation of Articles 7-10 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs for intentional introduction to the environment:
FR
Le Burundi n'a pas encore adopté sa loi sur la biosécurité qui comprend les mesures administratives sur le fonctionnement de la procédure d'accord préalable en connaissance de cause pour tout mouvement transfrontalier.
Article 11 – Procedure for living modified organisms intended for direct use as food or feed, or for processing (LMOs-FFP)
51. Has your country adopted specific law(s) or regulation(s) for decision-making regarding domestic use, including placing on the market, of LMOs-FFP?
  • No
52. Has your country established legal requirements for the accuracy of information to be provided by the applicant?
  • No
53. Has your country established a mechanism to ensure that decisions regarding LMOs-FFP that may be subject to transboundary movement will be communicated to the Parties through the BCH?
  • No
54. Has your country established a mechanism for taking decisions on the import of LMOs-FFP?
  • No
55. Has your country declared through the BCH that in the absence of a regulatory framework its decisions prior to the first import of an LMO-FFP will be taken according to Article 11.6 of the Cartagena Protocol on Biosafety?
  • No
56. Has your country indicated its needs for financial and technical assistance and capacity building in respect of LMOs-FFP?
  • No
57. Has your country ever taken a decision on LMOs-FFP (either on import or domestic use)?
  • No
63. Here you may provide further details on the implementation of Article 11 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs-FFP:
FR
Le projet de loi et le Cadre National de Biosécurité prévoient des mécanismes pour la gestion des OGM destinés à être utilisés pour l'alimentation humaine et animale et à être transformés mais ces mécanismes ne pourront être fonctionnels qu'avec l'adoption de la loi. Par ailleurs, notre pays n'a pas été et n'est pas une Partie importatrice d'OVM
Article 12 – Review of decision
64. Has your country established a mechanism for the review and change of a decision regarding an intentional transboundary movement of LMOs?
  • No
65. Has your country ever received a request for a review of a decision?
  • No
66. Has your country ever reviewed / changed a decision regarding an intentional transboundary movement of LMOs?
  • No
67. In the current reporting period, how many decisions were reviewed and/or changed regarding an intentional transboundary movement of an LMO?
  • None
71. Here you may provide further details on the implementation of Article 12 in your country:
FR
Le projet de loi et le Cadre National de Biosécurité prévoient des mécanisme pour la gestion des OGM destinés à être utilisés pour l'alimentation humaine et animale et à être transformés mais ces mécanismes ne pourront être fonctionnels qu'avec l'adoption de la loi. Par ailleurs, notre pays n'a pas été  et n'est pas une Partie importatrice d'OVM
Article 13 – Simplified procedure
72. Has your country established a system for the application of the simplified procedure regarding an intentional transboundary movement of LMOs?
  • No
73. Has your country ever applied the simplified procedure?
  • No
75. In the current reporting period, how many LMOs has your country applied the simplified procedure to?
  • None
76. Here you may provide further details on the implementation of Article 13 in your country:
FR
Le projet de loi et le Cadre National de Biosécurité prévoient des mécanismes pour la gestion des OGM destinés à être utilisés pour l'alimentation humaine et animale et à être transformés mais ces mécanismes ne pourront être fonctionnels qu'avec l'adoption de la loi. Par ailleurs, notre pays n'a pas été et n'est pas une Partie importatrice d'OVM
Article 14 – Bilateral, regional and multilateral agreements and arrangements
77. Has your country entered into any bilateral, regional or multilateral agreements or arrangements?
  • No
80. Here you may provide further details on the implementation of Article 14 in your country:
FR
Le pays n'a pas encore conclu d'accord ou arrangements bilatéraux, régionaux ou multilatéraux.
Article 15 – Risk assessment
81. Has your country established a mechanism for conducting risk assessments prior to taking decisions regarding LMOs?
  • No
83. Has your country established guidelines for how to conduct risk assessments prior to taking decisions regarding LMOs?
  • Yes
84. Has your country acquired the necessary domestic capacity to conduct risk assessment?
  • No
85. Has your country established a mechanism for training national experts to conduct risk assessments?
  • No
86. Has your country ever conducted a risk assessment of an LMO for intentional introduction into the environment?
  • No
87. Has your country ever conducted a risk assessment of an LMO intended for direct use as food or feed, or for processing?
  • No
88. If your country has taken decision(s) on LMOs for intentional introduction into the environment or on domestic use of LMOs-FFP, were risk assessments conducted for all decisions taken?
  • Not applicable
89. Has your country submitted summary reports of the risk assessments to the BCH?
  • No
90. In the current reporting period, if your country has taken decisions regarding LMOs, how many risk assessments were conducted in the context of these decisions?
  • None
91. Has your country ever required the exporter to conduct the risk assessment(s)?
  • Not applicable
92. Has your country ever required the notifier to bear the cost of the risk assessment(s) of LMOs?
  • Not applicable
93. Here you may provide further details on the implementation of Article 15 in your country:
FR
Le Cadre National de Biosécurité donne des ligne directrices sur l'évaluation des risques. Mais, notre pays n'a pas été et n'est pas jusqu'à présent une Partie importatrice d'OVM
Article 16 – Risk management
94. Has your country established and maintained appropriate and operational mechanisms, measures and strategies to regulate, manage and control risks identified in risk assessments for:
94.1) LMOs for intentional introduction into the environment?
  • No
94.2) LMOs intended for direct use as food or feed, or for processing?
  • No
95. Has your country established and maintained appropriate measures to prevent unintentional transboundary movements of LMOs?
  • No
96. Has your country taken measures to ensure that any LMO, whether imported or locally developed, undergoes an appropriate period of observation that is commensurate with its life-cycle or generation time before it is put to its intended use?
  • No
97. Has your country cooperated with other Parties with a view to identifying LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
  • No
98. Has your country cooperated with other Parties with a view to taking measures regarding the treatment of LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
  • No
99. Here you may provide further details on the implementation of Article 16 in your country, including any details regarding risk management strategies, also in case of lack of scientific certainty on potential adverse effects of LMOs:
FR
Le projet de loi prévoit des mesures pour la gestion des risques. En attendant son adoption, le Burundi n'a pas mis en place d'autres systèmes de gestion des risques et n' a pas collaboré avec d'autres parties afin de prendre des mesures sur la gestion des risques.
Article 17 – Unintentional transboundary movements and emergency measures
100. Has your country made available to the BCH the relevant details setting out its point of contact for the purposes of receiving notifications under Article 17?
  • Yes
101. Has your country established a mechanism for addressing emergency measures in case of unintentional transboundary movements of LMOs that are likely to have significant adverse effect on biological diversity?
  • No
102. Has your country implemented emergency measures in response to information about releases that led, or may have led, to unintentional transboundary movements of LMOs?
  • No
103. In the current reporting period, how many times has your country received information concerning occurrences that led, or may have led, to unintentional transboundary movement(s) of one or more LMOs to or from territories under its jurisdiction?
  • Never
107. Here you may provide further details on the implementation of Article 17 in your country:
FR
L'Autorité Nationale Compétente habilitée à recevoir les notifications données en vertu de l'article 17 est déjà publié au Centre d'échange d'information sur la prévention des risques biotechnologiques. De plus, le projet de loi sur la biosécurité en attente d'adoption prévoit des mesures d'urgence en cas de libération non intentionnelle d'OGM.
Article 18 – Handling, transport, packaging and identification
108. Has your country taken measures to require that LMOs that are subject to transboundary movement are handled, packaged and transported under conditions of safety, taking into account relevant international rules and standards?
  • No
109. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is not known through means such as identity preservation systems, they may contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
  • No
110. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is known through means such as identity preservation systems, they contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
  • No
111. Has your country taken measures to require that documentation accompanying LMOs that are destined for contained use clearly identifies them as living modified organisms and specifies any requirements for the safe handling, storage, transport and use, the contact point for further information, including the name and address of the individual and institution to whom the LMO are consigned?
  • No
112. Has your country taken measures to require that documentation accompanying LMOs that are intended for intentional introduction into the environment of the Party of import, clearly identifies them as living modified organisms; specifies the identity and relevant traits and/or characteristics, any requirements for the safe handling, storage, transport and use, the contact point for further information and, as appropriate, the name and address of the importer and exporter; and contains a declaration that the movement is in conformity with the requirements of this Protocol applicable to the exporter?
  • No
113. Does your country have the capacity to enforce the requirements of identification and documentation of LMOs?
  • No
114. Has your country established procedures for the sampling and detection of LMOs?
  • No
115. Here you may provide further details on the implementation of Article 18 in your country:
FR
Le projet de loi sur la biosécurité en cours d'analyse par les instances habilitées exige que tout OVM ou produit dérivé d'OVM soit clairement identifié et étiqueté en tant que tel et l'identification doit mentionner spécifiquement ses traits et caractéristiques suffisamment détaillés pour en assurer la traçabilité.
Article 19 – Competent National Authorities and National Focal Points
116. Has your country designated one national focal point for the Cartagena Protocol to be responsible for liaison with the Secretariat?
  • Yes
117. Has your country designated one national focal point for the Biosafety Clearing-House to liaise with the Secretariat regarding issues of relevance to the development and implementation of the BCH?
  • Yes
118. Has your country designated one or more competent national authorities, which are responsible for performing the administrative functions required by the Cartagena Protocol on Biosafety and are authorized to act on your country’s behalf with respect to those functions?
  • Yes, one
120. Has your country made available the required information referred in questions 116-119 to the BCH?
  • Yes, all information
122. Has your country established adequate institutional capacity to enable the competent national authority(ies) to perform the administrative functions required by the Cartagena Protocol on Biosafety?
  • No
123. Here you may provide further details on the implementation of Article 19 in your country:
FR
Le pays a déjà désigné l'Autorité Nationale Compétente et les correspondants nationaux. Mais, il reste à mettre en place d'autres structures pertinentes entre autre le Comité national d'Experts pour faciliter la prise de décision par l'Autorité Nationale Compétente
Article 20 – Information Sharing and the Biosafety Clearing-House (BCH)
124. Please provide an overview of the status of the information provided by your country to the BCH by specifying for each category of information whether it is available and whether it has been submitted to the BCH.
124.a) Existing national legislation, regulations and guidelines for implementing the Protocol, as well as information required by Parties for the advance informed agreement procedure (Article 20, paragraph 3 (a))
  • Information not available
124.b) National laws, regulations and guidelines applicable to the import of LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 5)
  • Information not available
124.c) Bilateral, multilateral and regional agreements and arrangements (Articles 14, paragraph 2 and 20, paragraph 3 (b))
  • Information not available
124.d) Contact details for competent national authorities (Article 19, paragraphs 2 and 3), national focal points (Article 19, paragraphs 1 and 3), and emergency contacts (Article 17, paragraph 3 (e))
  • Information available and in the BCH
124.e) Reports submitted by the Parties on the operation of the Protocol (Article 20, paragraph 3 (e))
  • Information not available
124.f) Decisions by a Party on regulating the transit of specific living modified organisms (LMOs) (Article 6, paragraph 1)
  • Information not available
124.g) Occurrence of unintentional transboundary movements that are likely to have significant adverse effects on biological diversity (Article 17, paragraph 1)
  • Information not available
124.h) Illegal transboundary movements of LMOs (Article 25, paragraph 3)
  • Information not available
124.i) Final decisions regarding the importation or release of LMOs (i.e. approval or prohibition, any conditions, requests for further information, extensions granted, reasons for decision) (Articles 10, paragraph 3 and 20, paragraph 3(d))
  • Information not available
124.j) Information on the application of domestic regulations to specific imports of LMOs (Article 14, paragraph 4)
  • Information not available
124.k) Final decisions regarding the domestic use of LMOs that may be subject to transboundary movement for direct use as food or feed, or for processing (Article 11, paragraph 1)
  • Information not available
124.l) Final decisions regarding the import of LMOs intended for direct use as food or feed, or for processing that are taken under domestic regulatory frameworks (Article 11, paragraph 4) or in accordance with annex III (Article 11, paragraph 6) (requirement of Article 20, paragraph 3(d))
  • Information not available
124.m) Declarations regarding the framework to be used for LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 6)
  • Information not available
124.n) Review and change of decisions regarding intentional transboundary movements of LMOs (Article 12, paragraph 1)
  • Information not available
124.o) LMOs granted exemption status by each Party (Article 13, paragraph 1)
  • Information not available
124.p) Cases where intentional transboundary movement may take place at the same time as the movement is notified to the Party of import (Article 13, paragraph 1)
  • Information not available
124.q) Summaries of risk assessments or environmental reviews of LMOs generated by regulatory processes and relevant information regarding products thereof (Article 20, paragraph 3 (c))
  • Information not available
125. Has your country established a mechanism for strengthening the capacity of the BCH National Focal Point to perform its administrative functions?
  • No
126. Has your country established a mechanism for the coordination among the BCH National Focal Point, the Cartagena Protocol focal point, and the competent national authority(ies) for making information available to the BCH?
  • No
127. Does your country use the information available in the BCH in its decision making processes on LMOs?
  • No
128. Has your country experienced difficulties accessing or using the BCH?
  • Yes
129. If you answered Yes to question 128, has your country reported these problems to the BCH or the Secretariat?
  • Yes
130. Is the information submitted by your country to the BCH complete and up-to date?
  • No
131. Here you may provide further details on the implementation of Article 20 in your country:
FR
Le pays fournit régulièrement les données dont il a à sa disposition. Cependant le pays n'a pas fourni beaucoup d'informations du fait qu'elles ne sont pas encore disponibles notamment en matière de renforcement des capacités
Article 21 – Confidential information
132. Has your country established procedures to protect confidential information received under the Protocol?
  • No
133. Does your country allow the notifier to identify information that is to be treated as confidential?
  • No
134. Here you may provide further details on the implementation of Article 21 in your country:
FR
Le projet de loi sur la biosécurité en cours d'analyse prévoit des procédures pour protéger les renseignements confidentiels reçus en vertu du Protocole
Article 22 – Capacity-building
135. Has your country received external support or benefited from collaborative activities with other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
136. If you answered Yes to question 135, how were these resources made available?
  • Bilateral channels
137. Has your country provided support to other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • No
139. Is your country eligible to receive funding from the Global Environment Facility (GEF)?
  • Yes
140. Has your country ever initiated a process to access GEF funds for building capacity in biosafety?
  • Yes
141. If you answered Yes to question 140, how would you characterize the process?
Please add further details about your experience in accessing GEF funds under question 150.
  • Average
142. Has your country ever received funding from the GEF for building capacity in biosafety?
  • Development of national biosafety frameworks
  • Building Capacity for Effective Participation in the BCH (Phase I)
143. During the current reporting period, has your country undertaken activities for the development and/or strengthening of human resources and institutional capacities in biosafety?
  • No
145. During the current reporting period, has your country carried out a capacity-building needs assessment?
  • No
146. Does your country still have capacity-building needs?
  • Yes
147. If you answered Yes to question 146, indicate which of the following areas still need capacity-building.
  • Institutional capacity
  • Human resources capacity development and training
  • Risk assessment and other scientific and technical expertise
  • Risk management
  • Public awareness, participation and education in biosafety
  • Information exchange and data management including participation in the Biosafety Clearing-House
  • Scientific, technical and institutional collaboration at subregional, regional and international levels
  • Technology transfer
  • Identification of LMOs, including their detection
  • Socio-economic considerations
  • Implementation of the documentation requirements under Article 18.2 of the Protocol
  • Handling of confidential information
  • Measures to address unintentional and/or illegal transboundary movements of LMOs
  • Scientific biosafety research relating to LMOs
  • Taking into account risks to human health
148. Has your country developed a capacity-building strategy or action plan?
  • No
149. Has your country submitted the details of national biosafety experts to the Roster of Experts in the BCH?
  • No
150. Here you may provide further details on the implementation of Article 22 in your country, including further details about your experience in accessing GEF funds:
FR
Le Burundi n'a pas encore mené une évaluation des besoins en renforcement des capacités pour la mise en œuvre du protocole. En matière de biosécurité, le Burundi est appuyé par le FEM à travers le PNUE comme Agence d'exécution. Cette procédure est plus moyennement facile par rapport aux autres systèmes de financement que le Burundi connaît.
Article 23 – Public awareness and participation
151. Has your country established a strategy or put in place legislation for promoting and facilitating public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • No
152. Has your country established a biosafety website?
  • Yes
153. Has your country established a mechanism to ensure public access to information on living modified organisms that may be imported?
  • No
154. Has your country established a mechanism to consult the public in the decision-making process regarding LMOs?
  • No
155. Has your country established a mechanism to make available to the public the results of decisions taken on LMOs?
  • No
156. Has your country taken any initiative to inform its public about the means of public access to the Biosafety Clearing-House?
  • Yes
157. In the current reporting period, has your country promoted and facilitated public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • Yes, to a limited extent
158. If you answered Yes to question 157, has your country cooperated with other States and international bodies?
  • No
159. In the current reporting period, how many times has your country consulted the public in the decision-making process regarding LMOs and made the results of such decisions available to the public?
  • None
160. Here you may provide further details on the implementation of Article 23 in your country:
FR
Des actions de sensibilisation sur les OVMs ont été menées dans le cadre des Projets sur l'élaboration du Cadre National de Biosécurité et la mis en place du BCH. Mais, seules les institutions étatiques et les associations nationales ont été sensibilisées.
Article 24 – Non-Parties
161. Has your country entered into any bilateral, regional, or multilateral agreement with non-Parties regarding transboundary movements of LMOs?
  • No
162. Has your country ever imported LMOs from a non-Party?
  • No
163. Has your country ever exported LMOs to a non-Party?
  • No
167. Here you may provide further details on the implementation of Article 24 in your country:
FR
Le pays n'a pas conclu d'accord bilatéral, régional ou multilatéral avec des non parties concernant des mouvements transfrontières d'OVM.
Article 25 – Illegal transboundary movements
168. Has your country adopted domestic measures aimed at preventing and/or penalizing transboundary movements of LMOs carried out in contravention of its domestic measures to implement this Protocol?
  • No
169. Has your country established a strategy for detecting illegal transboundary movements of LMOs?
  • No
170. In the current reporting period, how many times has your country received information concerning cases of illegal transboundary movements of an LMO to or from territories under its jurisdiction?
  • Never
175. Here you may provide further details on the implementation of Article 25 in your country:
FR
Le pays n'a jamais connu de mouvements transfrontières illicites et n'a pas encore pris de mesures nationales visant à prévenir ou à réprimer les mouvements tranfrontiières illicites.
Article 26 – Socio-economic considerations
176. If your country has taken a decision on import, has it ever taken into account socio-economic considerations arising from the impact of the LMO on the conservation and sustainable use of biological diversity?
  • Not applicable
177. Has your country cooperated with other Parties on research and information exchange on any socio-economic impacts of LMOs?
  • No
178. Here you may provide further details on the implementation of Article 26 in your country:
FR
Le pays n'a pas encore pris de décisions d'importer des OVMs
Article 27 – Liability and Redress
179. Has your country signed the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress?
  • No
180. Has your country initiated steps towards ratification, acceptance or approval of the Nagoya-Kuala Lumpur Supplementary Protocol?
  • Yes
181. Here you may provide further details on any activities undertaken in your country towards the implementation of the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress:
FR
Le pays a entrepris les procédures de signature du Protocole de Nagoya Kuala Lumpur sur la responsabilité et la réparation par le biais du Ministère des Affaires Etrangères et de la Coopération, par la suite il va entreprendre les procédures de ratification au niveau du gouvernement et du parlement
Article 33 – Monitoring and reporting
182. Has your country submitted the previous national reports (Interim and First National Reports)?
  • No
183. If your country did not submit previous reports, indicate the main challenges that hindered the submission
  • No obligation to submit (e.g. country was not a Party at the time)
  • Le pays n'a pas soumis de rapports antérieurs car il n'était pas encore partie au Protocole
Other information
184. Please use this field to provide any other information on issues related to national implementation of the Protocol, including any obstacles or impediments encountered.
FR
Pour arriver à appliquer le Protocole au niveau national, le Burundi devra d'abord adopter la loi sur la biosécurité qui aidera l'opérationnalisation du Cadre National de Biosécurité et qui facilitera la mise en place des structures pour la prise de décision. Il y a également un maque de moyens financiers pour la mise en œuvre du protocole. Des besoins pressants de renforcement des capacités humaines, institutionnelles et matérielles se font sentir. Le Burundi a également le besoin de sensibiliser le public sur les questions de biosécurité.

Re: Q. 14- Le Burundi est Partie au Protocole depuis le 31 Décembre 2008

Re: Q. 135- Le pays a déjà reçu des financements de part du FEM et autres bailleurs (Institut Royal des Sciences Naturelle de Bruxelles, Belgique) qui lui ont premis d'élaborer son Cadre National de Biosécurité, son projet de loi sur la biosécurité, la mise en place et le fonctionnement du BCH, mais aussi la participation à des réunions de formation sur l'évaluation et la gestion des risques et sur le fonctionnement du BCH.

Re: Q. 136- Regional channels & Multilateral channels aussi

Re: Q. 137- Le pays est en voie de développement et ne peut pas fournir un soutien aux autres
Comments on reporting format
185. Please use this field to provide any other information on difficulties that you have encountered in filling in this report.
FR
Pas de difficultés particulières. Cependant, le formulaire n'offre pas les possibilités de donner les niveaux d'exécution de certaines mesures notamment des mesures non encore adoptées mais figurant dans les projets de lois en cours d'adoption et dans  le cadre national de biosécurité déjà fonctionnel.
Survey on indicators of the Strategic Plan (2014)
In decision BS-VI/15, Parties requested the Executive Secretary to conduct a dedicated survey to gather information corresponding to indicators in the Strategic Plan that could not be obtained from the second national reports or through other existing mechanisms.

The answers to the survey are displayed below.
When did your national biosafety framework become operational?
indicator 1.1.1
  • 2006
Here you may provide further details
FR
There  is no additional funding that our country has mobilized in the last four years to support implementation of of the Biosafety Protocol
Survey 4. How many biosafety short-term training programmes and/or academic courses are offered annually in your country?
indicator 1.2.3
  • None
Here you may provide further details
FR
There are no short-term training programmes or academic courses offered in our country because ther is lack of human capacities
Survey 5. Does your country have in place a functional national mechanism for coordinating biosafety capacity-building initiatives?
indicator 1.2.4
  • No
Here you may provide further details
FR
There is no fucntional national mechanism for coordinating biosafety capacity-building initiatives but there is a National Institure for Environment and Nature Conservation which can play the role of national mechanisms for coordinating biosafety capacity-building initiatives in Burundi
Survey 6. How much additional funding (in the equivalent of US dollars) has your country mobilized in the last four years to support implementation of the Biosafety Protocol, beyond the regular national budgetary allocation?
indicator 1.2.5
  • No funds mobilized
Survey 7. Does your country have predictable and reliable funding for building capacity for the effective implementation of the Protocol?
indicator 1.2.6
  • No
Here you may provide further details
FR
Our country does not have predictable and reliable funding for building capacity for the effective implementattion-of the Protocol
Survey 8. How many LMO-related collaborative bilateral/multilateral arrangements has your country established with other Parties/non-Parties?
indicator 1.2.8
  • None
Here you may provide further details
FR
There is non bilateral or multilateral arrangements that our counry has establissed with other parties related to LMO
Survey 9. Has your country adopted or used any guidance documents for the purpose of conducting risk assessment and/or risk management?
indicator 1.3.1.1
Survey 9.a) Risk assessment
  • No
Survey 9.b) Risk management
  • No
Here you may provide further details
FR
Our country has not yet adopted or used any gguidance documents for the purpose of conducting risk assessment or risk management
Survey 10. Has your country adopted or used any guidance documents for the purpose of evaluating risk assessment reports submitted by notifiers?
indicator 1.3.1.2
  • No
Here you may provide further details
FR
Our country has not yet adopted or used any gguidance documents for the purpose of evaluating risk assessment report submitted by notifiers
Survey 11. Has your country adopted any common approaches to risk assessment with other countries?
indicator 1.3.2
  • Yes
Here you may provide further details
FR
Recently this year, COMESA  Member states have adopted  in  Addis Ababa a commun approche to  rsik assessment
Survey 12. Has your country ever conducted a risk assessment of an LMO?
indicator 1.3.3
  • No
Here you may provide further details
FR
Our country has not yet conducted a risk assessment of an LMO because our country does not yet import LMO
Survey 13. Does your country have the capacity to identify, assess and/or monitor living modified organisms or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity, taking into account risks to human health?
indicator 1.4.2
Survey 13.a) Identify
  • No
Survey 13.b) Assess
  • No
Survey 13.c) Monitor
  • No
Here you may provide further details
FR
Our country does not have the capacity to identify, assess or monitor LMO that may have adverse effect on the conservation of biodiversity because  of lack of human resources qualified and infrastructures ( laboratories)
Survey 14. Does your country have available any guidance for the purpose of ensuring the safe handling, transport, and packaging of living modified organisms?
indicator 1.6.4
  • No
Here you may provide further details
FR
Our country has not yet elaborated or used any gguidance documents for the purpuse of ensuring the safe handling, transport and packging of living modified organisms because of lack of funds and human resources to develop them.
Survey 15. Does your country have any specific approaches or requirements that facilitate how socio-economic considerations should be taken into account in LMO decision making?
indicator 1.7.2
  • No
Here you may provide further details
FR
Our country has no specific requirements that facilitate how sosio-economic considerations should be ttaken into account in LMO decision making
Survey 16. How many peer-reviewed published materials has your country used for the purpose of elaborating or determining national actions with regard to socio-economic considerations?
indicator 1.7.1
  • None
Survey 17. What is your country's experience, if any, in taking socio-economic considerations into account in LMO decision making?
indicator 1.7.3
FR
Our country does not have any experience in taking socio-economic considerations in LMO decision making because he has not yet import LMO
Survey 18. Does your country have the capacity to take appropriate measures in the event that an LMO is unintentionally released?
indicator 1.8.3
  • No
Here you may provide further details
FR
No capacity available
Survey 19. How many people in your country have been trained in risk assessment, monitoring, management and control of LMOs?
indicator 2.2.3
Survey 19.a) Risk assessment
  • One or more
Survey 19.b) Monitoring
  • None
Survey 19.c) Management / Control
  • None
Here you may provide further details
FR
Some persons have been trained in risk assessment but there very limited
Survey 20. Does your country have the infrastructure (e.g. laboratory facilities) for monitoring or managing LMOs?
indicator 2.2.4
  • No
Here you may provide further details
FR
There are no laboratories facilities for monitoring or managing LMOs.
Survey 21. Is your country using training material and/or technical guidance for training in risk assessment and risk management of LMOs?
indicator 2.2.5
  • No
Here you may provide further details
FR
Our country does not used training material or technical guidance for training in risk assessment and risk management because there not available.
Survey 22. Are the available training materials and technical guidance on risk assessment and risk management of LMOs sufficient and effective?
indicator 2.2.6
Survey 22.a) Sufficient
  • No
Survey 22.b) Effective
  • No
Here you may provide further details
FR
See the response given on question 21
Survey 23. How many customs officers in your country have received training in the identification of LMOs?
indicator 2.3.1
  • None
Here you may provide further details
FR
There are no customs officers who have received training in the identification of LMOs
Survey 24. How many laboratory personnel in your country have received training in detection of LMOs?
indicator 2.3.1
  • None
Here you may provide further details
FR
There are  no specialized laboratories in the conutry to detect LMOs
Survey 25. Does your country have reliable access to laboratory facilities for the detection of LMOs?
indicator 2.3.2
  • No
Here you may provide further details
FR
There are  no specialized laboratories in the country to detect LMOs
Survey 26. How many laboratories in your country are certified for LMO detection?
indicator 2.3.3
  • None
Here you may provide further details
FR
There are  no specialized laboratories in the country to detect LMOs
Survey 27. How many of the certified laboratories in the previous question are operational?
indicator 2.3.4
  • None
Here you may provide further details
FR
There are  no specialized laboratories in the conutry to detect LMOs
Survey 28. Has your country received any financial and/or technical assistance for capacity-building in the area of liability and redress relating to living modified organisms?
indicator 2.4.1
  • Yes
Here you may provide further details
FR
The Cartagena Focal Point has participated in some training seminars in the area of liability and redress relating to living modified organisms organized by the CBD Secretariat.
Survey 29. Does your country have administrative or legal instrument that provide for response measures for damage to biodiversity resulting from living modified organisms?
indicator 2.4.2
  • No
Here you may provide further details
FR
Our legal instruments do not provise response for mesures fo damage biodiversity resulting from living modified organisms.
Survey 30. Has your country informed the public about existing modalities for public participation in the decision-making process regarding living modified organisms?
indicator 2.5.2
  • No
Here you may provide further details
FR
The public is not informed about existing modalities for his participation in the decision-making process regarding living modified organisms.
Survey 31. If you answered yes to the previous question, please indicate the modalities used to inform the public?
indicator 2.5.2
  • N/A
Survey 33. How many academic institutions in your country are offering biosafety education and training courses and programmes?
indicator 2.7.1
  • None
Here you may provide further details
FR
There are no academic institutions that offer biosafety education in the country.
Survey 34. How many biosafety training materials and/or online modules are available in your country?
indicator 2.7.2
  • None
Survey 35. Does your country have in place a monitoring and/or an enforcement system?
indicator 3.1.6
Survey 35.a) Monitoring system
  • No
Survey 35.b) Enforcement system
  • No
Here you may provide further details
FR
The monitoring system is envisaged in biosafety law draft but it is not yet fonctional. It si about cases where an assessment of risks established subsequent to the authorization demontrates the existence of a risk to human and animal health or for the environment. In this case it is idicated that the competent national authority can susped the authirisation  while wiating fort additional and, if possible, order the products from the market and ban its use; impose modifications to the conditions of deliberate release; order the destruction of Genetically Modified Organisms.
Survey 36. Please indicate the number of regional, national and international events organized in relation to biosafety (e.g. seminars, workshops, press conferences, educational events, etc.,) in the last 2 years.
indicator 4.3.1
  • One or more
Here you may provide further details
FR
There has been one seminar organized by COMESA related to COMESA Policy in biosafety matter.
Survey 37. Please indicate the number of biosafety related publications that has been made available in your country in the last year.
indicator 4.3.2
  • None
Survey 38. If biosafety related publications were made available (see question above), please indicate which modalities were preferred.
indicator 4.3.2
  • N/A
Survey 39. How many collaborative initiatives (including joint activities) on the Cartagena Protocol and other Conventions and processes has your government established in the last 4 years?
indicator 5.2.1
  • One or more
Here you may provide further details
FR
In EAC sub-region, Parteners States are discussing road map for development of regional biosafety framework. Also, in the COMESA sub-region, member states have agreed on an common biosafety policy on urgene aid containing GMOs, risk assessment, ect..
Survey 40. Does your country have any awareness and outreach programmes on biosafety?
indicator 5.3.1
  • No
Survey 41. If you answered yes to the question above, please indicate what entity is responsible for carrying out the programmes and/or services and at which level the programmes take place.
indicator 5.3.1
E.g. local, national, etc.,
FR
N/A
Survey 42. Has your country designed and/or implemented an outreach/communication strategy on biosafety?
indicator 5.3.2
  • No
Here you may provide further details
FR
Not yet.
Survey 43. Please indicate the number of educational materials on biosafety that are available and accessible to the public.
indicator 5.3.4
  • None